Double-masked, randomized, parallel-group study comparing olopatadine 0.1% ophthalmic solution with cromolyn sodium 2% and levocabastine 0.05% ophthalmic preparations in children with seasonal allergic conjunctivitis

Current Therapeutic Research - Clinical and Experimental

Volumn 65, Issue 2, 2004, Pages 186-199

  Ciprandi, Giorgio ^a   Turner, Darell ^b   Gross, Robert D ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b ALCON RESEARCH LTD   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

cromolyn sodium; eye drops; levocabastine; olopatadine; placebo; seasonal allergic rhinoconjunctivitis

Indexed keywords

EID: 25444500592     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(04)90032-X     Document Type: Article

References (18)

1. European Commission Enterprise Directorate-General. Better Medicines for children: Proposed regulatory actions on paediatric medicinal products. Consultation Document. Int J Pharm Med 16 (2002) 25-29
2. Sharif N.A., Xu S.X., Miller S.T., et al. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases. J Pharmacol Exp Ther 278 (1996) 1252-1261
3. Yanni J.M., Stephens D.J., Miller S.T., et al. The in vitro and in vivo ocular pharmacology of olopatadine (AL-4943A), an effective anti-allergic/antihistaminic agent. J Ocul Pharmacol Ther 12 (1996) 389-400
4. Butrus S., Greiner J.V., Discepola M., and Finegold I. Comparison of the clinical efficacy and comfort of olopatadine hydrochloride 0.1% ophthalmic solution and nedocromil sodium 2% ophthalmic solution in the human conjunctival allergen challenge model. Clin Ther 22 (2000) 1462-1472
5. Abelson M.B., and Spitalny L. Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activity. Am J Ophthalmol 125 (1998) 797-804
6. Abelson M.B., and Turner D. A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitis. Clin Ther 25 (2003) 931-946
7. Aguilar A.J. Comparative study of clinical efficacy and tolerance in seasonal allergic conjunctivitis management with 0.1% olopatadine hydrochloride versus 0.05% ketotifen fumarate. Acta Ophthalmol Scand Suppl 230 (2000) 52-55
8. Katelaris C.H., Ciprandi G., Missotten L., et al., International Olopatadine Study Group. A comparison of the efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and cromolyn sodium 2% ophthalmic solution in seasonal allergic conjunctivitis. Clin Ther 10 (2002) 1561-1575
9. ®) eye drops 0.1% compared to levocabastine 0.05% in seasonal allergic conjunctivitis. Ophthal Res (September 2001) Supplement. Abstract 3201
10. Milliken G.A., and Johnson D.E. Analysis of Messy Data Vol 1 (1994), Chapman Hall, London
11. Littell R.C., Milliken G.A., Stroup W.W., and Wolfinger R.D. SAS System for Mixed Models (1996) 5.4.2
12. Friedlaender M.H. Current concepts in ocular allergy. Ann Allergy 67 (1991) 5-10
13. Friedlaender M.H. Current concepts in ocular allergy. Ann Allergy 67 (1991) 13
14. Hordijk G.J., Antvelink J.B., and Luwema R.A. Sublingual immunotherapy with a standardised grass pollen extract; a double-blind placebo-controlled study. Allergol lmmunopathol (Madrid) 26 (1998) 234-240
15. Odelram H., Bjõrkstén B., Klercker T., et al. Topical levocabastine versus sodium cromoglycate in allergic conjunctivitis. Allergy 44 (1989) 432-436
16. Vermeulen J., and Mercer M. Comparison of the efficacy and tolerability of topical levocabastine and sodium cromoglycate in the treatment of seasonal allergic rhinoconjunctivitis in children. Paediatr Allergy Immunol 5 (1994) 209-213
17. Möller C., Berg I.M., Berg T., et al. Nedocromil sodium 2% eye drops for twice-daily treatment of seasonal allergic conjunctivitis: A Swedish multicentre placebocontrolled study in children allergic to birch pollen. Clin Exp Allergy 24 (1994) 884-887
18. Leino M., Ennevaara K., Latvala A.L., et al. Double-blind group comparative study of 2% nedocromil sodium eye drops with 2% sodium cromoglycate and placebo eye drops in the treatment of seasonal allergic conjunctivitis. Clin Exp Allergy 22 (1992) 929-932